Literature DB >> 22899296

Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers.

David M Dorfman1, Aliakbar Shahsafaei, Miguel A Alonso.   

Abstract

CD200, an immunoglobulin superfamily membrane glycoprotein, is expressed in a number of B cell lymphoproliferative disorders, including primary mediastinal large B cell lymphoma, but not diffuse large B cell lymphoma, based on a preliminary study. Here, we compare the expression of CD200 with other markers of primary mediastinal large B cell lymphoma, including MAL and CD23, in formalin-fixed, paraffin-embedded histologic sections from a series of 35 cases of primary mediastinal large B cell lymphoma and 30 cases of diffuse large B cell lymphoma. CD200 exhibits the greatest staining sensitivity of the markers studied: 94%, compared with CD23 (69%), MAL (86%), TRAF (86%), and REL (77%). It exhibits staining specificity of 93%, similar to that of CD23 (93%) and MAL (97%), and greater than that of TRAF (77%) and REL (83%). We conclude that CD200 is a practical and useful marker for the diagnosis of primary mediastinal large B cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899296     DOI: 10.1038/modpathol.2012.129

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.

Authors:  Min Shi; Margaretha G M Roemer; Bjoern Chapuy; Xiaoyun Liao; Heather Sun; Geraldine S Pinkus; Margaret A Shipp; Gordon J Freeman; Scott J Rodig
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

Review 2.  Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.

Authors:  Charlotte Lees; Colm Keane; Maher K Gandhi; Jay Gunawardana
Journal:  Br J Haematol       Date:  2019-02-10       Impact factor: 6.998

Review 3.  Primary mediastinal large B cell lymphoma.

Authors:  Yating Yu; Xifeng Dong; Meifeng Tu; Huaquan Wang
Journal:  Thorac Cancer       Date:  2021-09-29       Impact factor: 3.500

4.  Immunohistochemistry with anti-MAL antibody and RNAscope with MAL probes are complementary techniques for diagnosis of primary mediastinal large B-cell lymphoma.

Authors:  Anthony Jacquier; Charlotte Syrykh; Isabelle Bedgedjian; Franck Monnien; Camille Laurent; Séverine Valmary-Degano; Pierre Brousset
Journal:  J Clin Pathol       Date:  2020-08-24       Impact factor: 3.411

5.  Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.

Authors:  Andrew S Flies; Nicholas B Blackburn; Alan Bruce Lyons; John D Hayball; Gregory M Woods
Journal:  Front Immunol       Date:  2017-05-03       Impact factor: 7.561

Review 6.  Pediatric mediastinal lymphoma.

Authors:  Saumyaranjan Mallick; Surabhi Jain; Prashant Ramteke
Journal:  Mediastinum       Date:  2020-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.